Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Aspaveli (Wirkstoff: Pegcetacoplan), ATC L04AJ03
Title in German as published on TED.
Contract award notice published on TED on 17 Jun 2026 by DAK-Gesundheit (Germany), CPV 33600000 Pharmaceutical products. Awarded to Swedish Orphan Biovitrum GmbH for EUR 1.
| Notice | 415398-2026 (can-standard) |
|---|---|
| Status | Contract award |
| Published | 17 Jun 2026 |
| Buyer | DAK-Gesundheit, Hamburg |
| Country | Germany |
| Main CPV | 33600000-6 Pharmaceutical products |
| Contract type | supplies |
| Procedure | neg wo call |
| Estimated value | EUR 1 excl. VAT |
| Awarded value | EUR 1 |
| Tenders received | 1 |
Daily EU tender alerts
Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.
Description
Gegenstand dieses Vertrags ist die Vereinbarung von Rabattzahlungen gemäß § 130a Abs. 8 bzw. 130c Absatz 1 SGB V auf das Arzneimittel Aspaveli (Wirkstoff: Pegcetacoplan), ATC L04AJ03 das von Swedish Orphan Biovitrum GmbH vertrieben und zu Lasten der DAK-G verordnet wird. Von dieser Vereinbarung erfasst wird das Arzneimittel Aspaveli in allen verfügbaren Wirkstärken, Darreichungsformen und Packungsgrößen.
Lots (1)
| Lot | Title | Estimated value | Deadline |
|---|---|---|---|
| LOT-0001 | Aspaveli (Wirkstoff: Pegcetacoplan), ATC L04AJ03 |
Winners
- Swedish Orphan Biovitrum GmbH Martinsried, Germany, size: large
More Pharmaceutical products in Germany
Get new pharmaceutical products tenders by email
A free weekly digest of new competition notices from TED. One-click unsubscribe in every email.
Daily EU tender alerts
Basic $19 a month, up to 5 filters. Pro $49 a month, up to 30 filters and tenders closing within 5 days. Charged in UAH at the National Bank of Ukraine rate on the payment day.